Benefit One

Sam Altman, chief executive of OpenAI, has spoken publicly about accepting the risks that come with developing artificial intelligence. He argued that the potential benefits of the technology justify pushing forward despite safety concerns. The remarks are drawing mixed reactions, with critics questioning whether industry leaders should be the ones weighing those trade-offs.

Nutrition content aimed at older adults is promoting a so-called number one seed said to dramatically improve blood flow in the legs for people over 70. The claim, spread widely online, has drawn large engagement, though no medical body endorses such exaggerated circulatory benefits. Viewers are advised to treat such supplements sceptically and consult a doctor about leg circulation problems.

Recipients of Social Security should expect two notices around the end of the year. One announces the 2027 cost-of-living increase to benefits. The other explains Medicare premium adjustments based on 2025 income, which can reduce take-home benefit increases for higher earners. The pairing matters because the same yearly raise can be partly offset by income-linked Medicare surcharges.

Only 14% of private-sector workers still have a traditional pension, and one retiree who bought an annuity to replace that missing income is highlighting a catch: Social Security treats annuity checks in two different ways depending on how the annuity was purchased and how payouts are structured. The case underscores how Americans increasingly self-fund retirement through annuities and 401(k)s, while navigating complex federal rules on how those payments affect or supplement their benefits.

Barron's reports that six stocks and one exchange-traded fund are surging following an unexpected result in Brazil's election. The shock outcome has triggered sharp moves in markets exposed to Brazil, with investors repositioning around the newly shaped political outlook. Analysts are watching how the incoming government's economic agenda will affect Brazilian assets and companies with heavy exposure to the country.

A dispute over backyard bird feeding is drawing attention: one neighbor asked everyone on the block to stop putting out feeders, and a resident has publicly pushed back with their response. The exchange touches on a common neighborhood debate over whether bird feeders attract unwanted pests or benefit local wildlife, and whether neighbors can dictate what others do on their own property.

Thailand, one of the world's most popular tourist destinations, is moving to tighten enforcement against foreigners, prompting debate over how welcoming the country should remain. The crackdown comes as the kingdom weighs the economic benefits of mass tourism against concerns over overstays, visa misuse and strain on local communities, and observers are watching how it affects arrivals.

A Hong Kong fencer has spoken about using both traditional Chinese medicine and Western medicine to treat and recover from sports injuries. The athlete chose a combined approach, drawing on treatments from both systems rather than relying on one alone. The choice has drawn attention to how elite athletes in Hong Kong manage injury recovery and whether integrative treatment could benefit others in sport.

A new study examining whether omega-3 supplements help children with ADHD has found only one modest benefit, according to coverage of the research. The findings temper expectations that fish oil supplements can meaningfully treat attention deficit hyperactivity disorder, though the specific measured benefit and study details are not elaborated in the available reporting.

Bernie Sanders has put forward legislation aimed at regulating artificial intelligence, and social media users are sharing plain-language explainers of what the bills would actually do. One widely shared post, framed as an "ELI5" explainer, sets out the bills' contents for people unfamiliar with them, prompting discussion about how the proposals would affect workers and AI development.

A person living with ALS, or amyotrophic lateral sclerosis, writes a personal reflection on artificial intelligence, arguing that its promise and its potential dangers are not abstract issues but deeply personal ones. The author describes how AI technologies could affect people with progressive diseases, both as tools that may help and as developments that carry risks.